Accrued Liabilities, Current in USD of Orgenesis Inc. from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Orgenesis Inc. quarterly Accrued Liabilities, Current history and change rate from Q4 2011 to Q3 2024.
  • Orgenesis Inc. Accrued Liabilities, Current for the quarter ending 30 Sep 2024 was $2.69M, a 33.5% increase year-over-year.
Accrued Liabilities, Current, Quarterly (USD)
Accrued Liabilities, Current, YoY Quarterly Change (%)

Orgenesis Inc. Quarterly Accrued Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.69M +$675K +33.5% 30 Sep 2024 10-Q 13 Nov 2024
Q2 2024 $2.79M +$554K +24.8% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $4.11M +$1.6M +63.6% 31 Mar 2024 10-Q 20 May 2024
Q4 2023 $2.22M -$430K -16.2% 31 Dec 2023 10-Q 13 Nov 2024
Q3 2023 $2.02M 30 Sep 2023 10-Q/A 15 Apr 2024
Q2 2023 $2.24M 30 Jun 2023 10-Q/A 15 Apr 2024
Q1 2023 $2.51M 31 Mar 2023 10-Q/A 15 Apr 2024
Q4 2022 $2.65M +$2.16M +446% 31 Dec 2022 10-K 15 Apr 2024
Q4 2021 $485K 31 Dec 2021 10-K 22 Mar 2023
Q4 2019 $1.99M +$488K +32.6% 31 Dec 2019 10-K 09 Mar 2020
Q3 2019 $1.72M +$908K +112% 30 Sep 2019 10-Q 07 Nov 2019
Q2 2019 $1.54M +$433K +39.2% 30 Jun 2019 10-Q 08 Aug 2019
Q1 2019 $1.53M +$73K +5.03% 31 Mar 2019 10-Q 08 May 2019
Q4 2018 $1.5M +$64K +4.46% 31 Dec 2018 10-K 09 Mar 2020
Q3 2018 $811K -$597K -42.4% 31 Aug 2018 10-Q 12 Oct 2018
Q2 2018 $1.1M -$271K -19.7% 31 May 2018 10-Q 17 Jul 2018
Q1 2018 $1.45M -$589K -28.9% 28 Feb 2018 10-Q 16 Apr 2018
Q4 2017 $1.44M +$230K +19.1% 30 Nov 2017 10-K 13 Feb 2019
Q3 2017 $1.41M +$1.41M 31 Aug 2017 10-Q 16 Oct 2017
Q2 2017 $1.38M +$400K +41% 31 May 2017 10-Q 24 Jul 2017
Q1 2017 $2.04M +$2.04M 28 Feb 2017 10-Q 19 Apr 2017
Q4 2016 $1.21M +$389K +47.7% 30 Nov 2016 10-K 28 Feb 2018
Q3 2016 $1.07K* -$550K 31 Aug 2016 10-Q 14 Oct 2016
Q2 2016 $975K +$616K +172% 31 May 2016 10-Q 15 Jul 2016
Q1 2016 $992* -$246K 29 Feb 2016 10-Q 14 Apr 2016
Q4 2015 $816K +$441K +118% 30 Nov 2015 10-K 28 Feb 2017
Q3 2015 $551K -$260K -32% 31 Aug 2015 10-Q 15 Oct 2015
Q2 2015 $359K -$239K -40% 31 May 2015 10-Q 15 Jul 2015
Q1 2015 $247K -$245K -49.8% 28 Feb 2015 10-Q 14 Apr 2015
Q4 2014 $375K -$11.1K -2.88% 30 Nov 2014 10-K 29 Feb 2016
Q3 2014 $811K +$644K +386% 31 Aug 2014 10-Q 15 Oct 2014
Q2 2014 $599K +$323K +117% 31 May 2014 10-Q 09 Jul 2014
Q1 2014 $491K +$362K +280% 28 Feb 2014 10-Q 10 Apr 2014
Q4 2013 $386K +$313K +428% 30 Nov 2013 10-K 19 Feb 2015
Q3 2013 $167K +$123K +279% 31 Aug 2013 10-Q 15 Oct 2013
Q2 2013 $275K +$174K +173% 31 May 2013 10-Q 15 Jul 2013
Q1 2013 $129K +$68K +111% 28 Feb 2013 10-Q 15 Apr 2013
Q4 2012 $73.1K +$68.1K +1363% 30 Nov 2012 10-K 19 Feb 2014
Q3 2012 $44.1K 31 Aug 2012 10-Q 15 Oct 2012
Q2 2012 $101K 31 May 2012 10-Q 25 Jun 2012
Q1 2012 $61.3K 29 Feb 2012 10-Q 20 Apr 2012
Q4 2011 $5K 30 Nov 2011 10-K 15 Feb 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.